This trial is studying a combination of drugs given before surgery to see how well it works in treating patients with triple-negative breast cancer.
- Stage III Breast Cancer
- Stage IA Breast Cancer
- Stage IIA Breast Cancer
- Stage IIIA Breast Cancer
- Progesterone Receptor Negative Breast Cancer
- HER2/Neu Negative Breast Cancer
- Androgen Receptor Positive
- Estrogen Receptor Negative Breast Cancer
- Stage IIIB Breast Cancer
- Stage IB Breast Cancer
- Triple Negative Breast Cancer
- Stage I Breast Cancer
- Stage II Breast Cancer
- Breast Cancer
- Stage IIB Breast Cancer
2 Primary · 1 Secondary · Reporting Duration: Up to 30 days after surgery
1 Treatment Group
Treatment (enzalutamide, paclitaxel)
1 of 1
37 Total Participants · 1 Treatment Group
Primary Treatment: Axillary Lymph Node Dissection · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 15 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many people are participating in this clinical trial?
"That is correct. The information available on clinicaltrials.gov supports that this trial is ongoing and seeking new participants. According to the site, the study was established on September 22nd, 2016 and was updated on September 22nd, 2020. They are looking for a total of 37 patients from 2 different locations." - Anonymous Online Contributor
Is recruitment still underway for this research project?
"The listing on clinicaltrials.gov shows that this study is still looking for patients to enroll. The trial was originally posted on September 22nd, 2016 and has since been updated multiple times, with the most recent edit being on September 22nd, 2020. Currently, 37 people are needed between 2 different sites." - Anonymous Online Contributor
Are there other ongoing research studies that focus on Axillary Lymph Node Dissection?
"At present, there are 973 clinical trials studying axillary lymph node dissection (ALND), with 264 of those trials in Phase 3. Most of the ALND clinical trials are located in Germantown, Tennessee, but there are 51812 locations worldwide conducting studies on this topic." - Anonymous Online Contributor
What is the standard medical procedure for Axillary Lymph Node Dissection?
"Axillary Lymph Node Dissection is a viable treatment option for patients struggling with neoplasm metastasis, kaposi sarcoma, and advance directives." - Anonymous Online Contributor
What is the most common side effect for patients who undergo Axillary Lymph Node Dissection?
"Phase 2 trials are limited to safety data, so our team has given Axillary Lymph Node Dissection a score of 2." - Anonymous Online Contributor